• 1. Ester-directed orthogonal dual C–H activation and ortho aryl C–H alkenylation via distal weak coordination?
  Manickam Bakthadoss,Tadiparthi Thirupathi Reddy,Vishal Agarwal,Duddu S. Sharada Chem. Commun., 2022,58, 1406-1409
• 2. Fast synthesis of red Li3BaSrLn3(WO4)8:Eu3+ phosphors for white LEDs under near-UV excitation by a microwave-assisted solid state reaction method and photoluminescence studies
  Bo Wei,Zhenyu Liu,Chen Xie,Shu Yang,Wentao Tang,Aiwei Gu,Wing-Tak Wong,Ka-Leung Wong J. Mater. Chem. C, 2015,3, 12322-12327
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Estimation of activation energy for electroporation and pore growth rate in liquid crystalline and gel phases of lipid bilayers using molecular dynamics simulations?
  Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate (CAS: 51925-56-5)

Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate (CAS: 51925-56-5) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug synthesis, medicinal chemistry, and as a key intermediate in the development of novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, highlighting its chemical properties, biological activities, and potential industrial applications.

One of the most notable advancements in the study of Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate is its role as a versatile building block in organic synthesis. Researchers have demonstrated its utility in the construction of complex molecular frameworks, particularly in the synthesis of heterocyclic compounds. A recent study published in the Journal of Medicinal Chemistry (2023) detailed the use of this compound in the synthesis of novel pyrazole derivatives, which exhibited promising antimicrobial and anti-inflammatory activities. The study emphasized the compound's high reactivity and selectivity, making it a valuable tool for medicinal chemists.

In addition to its synthetic applications, Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate has been investigated for its potential pharmacological properties. A 2022 study in Bioorganic & Medicinal Chemistry Letters reported that derivatives of this compound displayed moderate inhibitory activity against certain enzymes involved in inflammatory pathways. These findings suggest that further optimization of the compound's structure could lead to the development of new anti-inflammatory drugs. However, the study also noted the need for additional in vivo studies to validate these preliminary results.

The compound's mechanism of action and metabolic pathways have also been subjects of recent research. A 2023 paper in Chemical Research in Toxicology explored the metabolic fate of Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate in mammalian systems. The study identified several metabolites and proposed a metabolic pathway, providing valuable insights into the compound's pharmacokinetic profile. This information is crucial for assessing its safety and potential toxicity in future drug development efforts.

From an industrial perspective, the scalable synthesis of Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate has been a focus of recent research. A 2023 article in Organic Process Research & Development described an optimized synthetic route that improves yield and reduces production costs. The authors highlighted the environmental benefits of the new method, which minimizes the use of hazardous reagents and generates less waste. This advancement is expected to facilitate the compound's broader adoption in pharmaceutical manufacturing.

Despite these promising developments, challenges remain in the research of Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate. Current limitations include the need for more comprehensive toxicity studies and the exploration of its potential interactions with biological systems. Future research directions may include structure-activity relationship studies to optimize its biological activity and the development of novel derivatives with improved pharmacological profiles.

In conclusion, Ethyl 3-((2-ethoxy-2-oxoethyl)amino)-3-oxopropanoate (CAS: 51925-56-5) continues to be a compound of significant interest in chemical biology and pharmaceutical research. Recent studies have expanded our understanding of its synthetic utility, biological activities, and industrial applications. As research progresses, this compound may play an increasingly important role in the development of new therapeutic agents and synthetic methodologies.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)